Summit Securities Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Buy |
+996
| New | +$107K | 0.02% | 250 |
|
|
2023
Q3 | – | Sell |
-1,879
| Closed | -$102K | – | 442 |
|
|
2023
Q2 | $102K | Sell |
1,879
-933
| -33% | -$50.6K | 0.01% | 185 |
|
|
2023
Q1 | $141K | Buy |
2,812
+1,365
| +94% | +$68.4K | 0.01% | 145 |
|
|
2022
Q4 | $67K | Buy |
+1,447
| New | +$67K | ﹤0.01% | 457 |
|
|
2022
Q3 | – | Sell |
-2,991
| Closed | -$111K | – | 725 |
|
|
2022
Q2 | $111K | Buy |
2,991
+2,407
| +412% | +$89.3K | 0.01% | 255 |
|
|
2022
Q1 | $26K | Buy |
+584
| New | +$26K | ﹤0.01% | 455 |
|
|
2019
Q1 | – | Sell |
-14,116
| Closed | -$499K | – | 119 |
|
|
2018
Q4 | $499K | Buy |
+14,116
| New | +$499K | 0.04% | 83 |
|